Your browser doesn't support javascript.
loading
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study.
Zhu, Dalong; Gan, Shenglian; Liu, Yu; Ma, Jianhua; Dong, Xiaolin; Song, Weihong; Zeng, Jiao'e; Wang, Guixia; Zhao, Wenjuan; Zhang, Qiu; Li, Yukun; Fang, Hui; Lv, Xiaofeng; Shi, Yongquan; Tian, Haoming; Ji, Linong; Gao, Xin; Zhang, Lihui; Bao, Yuqian; Lei, Minxiang; Li, Ling; Zeng, Longyi; Li, Xiaoying; Hou, Xinghua; Zhao, Yu; Hu, Tianxin; Ge, Xiaoyun; Zhao, Guiyu; Li, Yongguo; Zhang, Yi; Chen, Li.
Afiliação
  • Zhu D; Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Gan S; The First People's Hospital of Changde City, Changde, China.
  • Liu Y; The Second Hospital of Jilin University, Changchun, China.
  • Ma J; Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Dong X; Jinan Central Hospital, Jinan, China.
  • Song W; Chenzhou No 1 People's Hospital, Chenzhou, China.
  • Zeng J; Jingzhou Central Hospital, Jingzhou, China; The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wang G; The First Hospital of Jilin University, Changchun, China.
  • Zhao W; The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhang Q; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Li Y; The Third Hospital of Hebei Medical University, Shijiazhuang, China.
  • Fang H; Tangshan Gongren Hospital, Tangshan, China.
  • Lv X; Army General Hospital of the People's Liberation Army, Beijing, China.
  • Shi Y; Shanghai Changzheng Hospital, Shanghai, China.
  • Tian H; West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
  • Ji L; Peking University People's Hospital, Beijing, China.
  • Gao X; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhang L; The Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Bao Y; Shanghai Sixth People's Hospital Affiliated with Shanghai Jiao Tong University, Shanghai, China.
  • Lei M; Xiangya Hospital Central South University, Changsha, China.
  • Li L; Shengjing Hospital of China Medical University, Shenyang, China.
  • Zeng L; The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li X; Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hou X; Hua Medicine, Shanghai, China.
  • Zhao Y; Hua Medicine, Shanghai, China.
  • Hu T; Hua Medicine, Shanghai, China.
  • Ge X; Hua Medicine, Shanghai, China.
  • Zhao G; Hua Medicine, Shanghai, China.
  • Li Y; Hua Medicine, Shanghai, China.
  • Zhang Y; Hua Medicine, Shanghai, China.
  • Chen L; Hua Medicine, Shanghai, China. Electronic address: lichen@huamedicine.com.
Lancet Diabetes Endocrinol ; 6(8): 627-636, 2018 08.
Article em En | MEDLINE | ID: mdl-29735394

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Biomarcadores / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Biomarcadores / Diabetes Mellitus Tipo 2 / Hipoglicemiantes Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido